ROGER GARCEAU

Insider Reports History

Location
Bedminster, NJ
Signature
/s/ Mary Grendell, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ROGER GARCEAU:

Company Role Class Num Shares Value Price $ Report Date Ownership
Entera Bio Ltd. Director Stock Option (right to buy) 108,333 01 Jan 2024 Direct
Protara Therapeutics, Inc. Director Stock Option (Right to Buy) 24,000 12 Jun 2025 Direct

Insider Reports Filed by ROGER GARCEAU

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TARA Protara Therapeutics, Inc. 12 Jun 2025 1 $0 4 Director 13 Jun 2025, 16:05
TARA Protara Therapeutics, Inc. 07 Jun 2024 1 $0 4 Director 10 Jun 2024, 18:00
ENTX Entera Bio Ltd. 01 Jan 2024 1 $0 4 Director 03 Jan 2024, 16:21
TARA Protara Therapeutics, Inc. 07 Jun 2023 1 $0 4 Director 08 Jun 2023, 16:10
ENTX Entera Bio Ltd. 02 Jan 2023 1 $0 4 Director 04 Jan 2023, 15:23
TARA Protara Therapeutics, Inc. 08 Jun 2022 1 $0 4 Director 09 Jun 2022, 16:10
ENTX Entera Bio Ltd. 01 Jan 2022 2 $0 4 Director 11 Jan 2022, 15:08
ENTX Entera Bio Ltd. 01 Jan 2022 0 $0 3 Director 11 Jan 2022, 15:01
TARA Protara Therapeutics, Inc. 09 Jun 2021 1 $0 4 Director 10 Jun 2021, 20:05